Mechanisms of neuroprotection by hemopexin: Modeling the control of heme and iron homeostasis in brain neurons in inflammatory states

Journal of Neurochemistry

Volumn 125, Issue 1, 2013, Pages 89-101

  Hahl, Peter ^a   Davis, Taron ^a   Washburn, Cecilia ^b   Rogers, Jack T ^b   Smith, Ann ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

APP; heme; hemopexin; iron; neuroprotection; stroke

Indexed keywords

ALBUMIN; AMYLOID PRECURSOR PROTEIN; HEME; HEME OXYGENASE 1; HEMOPEXIN; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; IRON; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE;

ARTICLE; BRAIN HEMORRHAGE; BRAIN NERVE CELL; CATABOLISM; CENTRAL NERVOUS SYSTEM; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENCEPHALITIS; ENDOCYTOSIS; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON BALANCE; IRON TRANSPORT; NEUROBLASTOMA CELL; NEUROPROTECTION; PORPHYRIN METABOLISM; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

AMYLOID BETA-PROTEIN PRECURSOR; APOPROTEINS; BRAIN; BRAIN INJURIES; CELL LINE, TUMOR; CEREBRAL HEMORRHAGE; ENDOCYTOSIS; ENZYME INDUCTION; HEME; HEME OXYGENASE-1; HEMOPEXIN; HUMANS; INFLAMMATION; NEURONS; PEROXIDES; REACTIVE OXYGEN SPECIES;

EID: 84875258941     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12165     Document Type: Article

References (73)

1. Alam J., and, Smith A., (1989) Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells. J. Biol. Chem. 264, 17637-17640.
2. Alam J., Stewart D., Touchard C., Boinapally S., Choi A. M., and, Cook J. L., (1999) Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274, 26071-26078.
3. Bandyopadhyay S., Ni J., Ruggiero A., Walshe K., Rogers M. S., Chattopadhyay N., Glicksman M. A., and, Rogers J. T., (2006) A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA. J. Biomol. Screen. 11, 469-480.
4. Bartzokis G., Sultzer D., Cummings J., Holt L. E., Hance D. B., Henderson V. W., and, Mintz J., (2000) In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch. Gen. Psychiatry 57, 47-53.
5. Beaven G. H., Chen S.-H., D'Albis A., and, Gratzer W. B., (1974) A spectroscopic study of the haemin-human-serum-albumin system. Eur. J. Biochem. 41, 539-546.
6. Brenner S. R., (2008) Neurovascular unit dysfunction: a vascular component of Alzheimer disease? Neurology 70, 243-244.
7. Buehler P. W., Abraham B., Vallelian F., et al,. (2009) Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 113, 2578-2586.
8. Chen J., and, Regan R. F., (2004) Heme oxygenase-2 gene deletion increases astrocyte vulnerability to hemin. Biochem. Biophys. Res. Commun. 318, 88-94.
9. Chen L., Zhang X., Chen-Roetling J., and, Regan R. F., (2010) Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. J. Neurosurg. 114, 1159-1167.
10. Cho H. H., Cahill C. M., Vanderburg C. R., Scherzer C. R., Wang B., Huang X., and, Rogers J. T., (2010) Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J. Biol. Chem. 285, 31217-31232.
11. Cordonnier C., and, van der Flier W. M., (2011) Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain 134, 335-344.
12. Crapper McLachlan D. R., Dalton A. J., Kruck T. P., Bell M. Y., Smith W. L., Kalow W., and, Andrews D. F., (1991) Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304-1308.
13. Davies D. M., Smith A., Muller-Eberhard U., and, Morgan W. T., (1979) Hepatic subcellular metabolism of heme from heme-hemopexin: incorporation of iron into ferritin. Biochem. Biophys. Res. Commun. 91, 1504-1511.
14. Duce J. A., Tsatsanis A., Cater M. A., et al,. (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867.
15. Eskew J. D., Vanacore R. M., Sung L., Morales P. J., and, Smith A., (1999) Cellular protection mechanisms against extracellular heme: heme- hemopexin, but not free heme, activates the N-terminal c-Jun kinase. J. Biol. Chem. 274, 638-648.
16. Figueiredo R. T., Fernandez P. L., Mourao-Sa D. S., Porto B. N., Dutra F. F., Alves L. S., Oliveira M. F., Oliveira P. L., Graca-Souza A. V., and, Bozza M. T., (2007) Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282, 20221-20229.
17. Flaherty M. M., Rish K. R., Smith A., and, Crumbliss A. L., (2008) An investigation of hemopexin redox properties by spectroelectrochemistry: biological relevance for heme uptake. Biometals 21, 239-248.
18. Fliss H., (1988) Oxidation of proteins in rat heart and lungs by polymorphonuclear leukocyte oxidants. Mol. Cell. Biochem. 84, 177-188.
19. Gebicka L., and, Banasiak E., (2012) Hypochlorous acid-induced heme damage of hemoglobin and its inhibition by flavonoids. Toxicol. In Vitro 26, 924-929.
20. Gottlieb Y., Truman M., Cohen L. A., Leichtmann-Bardoogo Y., and, Meyron-Holtz E. G., (2012) Endoplasmic reticulum anchored heme-oxygenase-1 faces the cytosol. Haematologica 97, 1489-1493.
21. Grinberg L. N., O'Brien P. J., and, Hrkal Z., (1999) The effects of heme-binding proteins on the peroxidative and catalatic activities of hemin. Free Radic. Biol. Med. 27, 214-219.
22. Guo Y., Schneider L. A., and, Wangensteen O. D., (1995) HOCl effects on tracheal epithelium: conductance and permeability measurements. J. Appl. Physiol. 78, 1330-1338.
23. Gupta S., Ahern K., Nakhl F., and, Forte F., (2011) Clinical usefulness of haptoglobin levels to evaluate hemolysis in recently transfused patients. Adv. Hematol. 2011, 389854.
24. Gutteridge J. M., and, Smith A., (1988) Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem. J. 256, 861-865.
25. Hershko C., (2007) Mechanism of iron toxicity. Food Nutr. Bull. 28, S500-S509.
26. Hrkal Z., Vodrazka Z., and, Kalousek I., (1974) Transfer of heme from ferrihemoglobin and ferrihemoglobin isolated chains to hemopexin. Eur. J. Biochem. 43, 73-78.
27. Hunt R. C., Handy I., and, Smith A., (1996a) Haem exacerbates reactive oxygen species toxicity to human retinal pigment epithelial cells while the haem-binding protein, haemopexin, is protective. J. Cell. Physiol. 168, 81-86.
28. Hunt R. C., Hunt D. M., Gaur N., and, Smith A., (1996b) Hemopexin in the human retina: protection of the retina against heme- mediated toxicity. J. Cell. Physiol. 168, 71-80.
29. Hunter M. J., and, McDuffie F. C., (1959) Molecular weight studies on human serum albumin after reduction and alkylation of disulfide bonds. J. Am. Chem. Soc. 81, 1400-1406.
30. Jiang Z.-Y., Woollard A. C. S., and, Wolff S. P., (1990) Hydrogen peroxide production during experimental protein glycation. FEBS Lett. 268, 69-71.
31. Kettle A. J., and, Winterbourn C. C., (1994) Assays for the chlorination activity of myeloperoxidase. Methods Enzymol. 233, 502-512.
32. Larsen R., Gozzelino R., Jeney V., et al,. (2010) A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2, 51ra71.
33. Li R. C., Saleem S., Zhen G., Cao W., Zhuang H., Lee J., Smith A., Altruda F., Tolosano E., and, Dore S., (2009) Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J. Cereb. Blood Flow Metab. 29, 953-964.
34. Li B., Takeda K., Ishikawa K., Yoshizawa M., Sato M., Shibahara S., and, Furuyama K., (2012) Coordinated expression of 6-phosphofructo-2-kinase/fructose- 2,6-bisphosphatase 4 and heme oxygenase 2: evidence for a regulatory link between glycolysis and heme catabolism. Tohoku J. Exp. Med. 228, 27-41.
35. Liang X., Lin T., Sun G., Beasley-Topliffe L., Cavaillon J. M., and, Warren H. S., (2009) Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages. J. Leukoc. Biol. 86, 229-235.
36. Lin Q., Weis S., Yang G., et al,. (2007) Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J. Biol. Chem. 282, 20621-20633.
37. Lin T., Sammy F., Yang H., Thundivalappil S., Hellman J., Tracey K. J., and, Warren H. S., (2012) Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation. J. Immunol. 189, 2017-2022.
38. Liu X., and, Zweier J. L., (2001) A real-time electrochemical technique for measurement of cellular hydrogen peroxide generation and consumption: evaluation in human polymorphonuclear leukocytes. Free Radic. Biol. Med. 31, 894-901.
39. McCall M. R., Carr A. C., Forte T. M., and, Frei B., (2001) Ldl modified by hypochlorous acid is a potent inhibitor of lecithin-cholesterol acyltransferase activity. Arterioscler. Thromb. Vasc. Biol. 21, 1040-1045.
40. McColl B. W., Rothwell N. J., and, Allan S. M., (2008) Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28, 9451-9462.
41. Morgan W. T., and, Muller-Eberhard U., (1972) Interactions of porphyrins with rabbit hemopexin. J. Biol. Chem. 247, 7181-7187.
42. Morgan W., and, Smith A,. (2001). Binding and transport of iron-porphyrins by hemopexin, in Advances in Inorganic Chemistry (, Mauk G., and, Sykes A. G.,eds), pp. 205-241. Academic Press, London, UK & San Diego, CA, USA.
43. Morgan W. T., Liem H. H., Sutor R. P., and, Muller-Ebergard U., (1976) Transfer of heme from heme-albumin to hemopexin. Biochim. Biophys. Acta 444, 435-445.
44. Morris J. C., (1966). The Acid Ionization Constant of HOCl from 5 to 35°. J. Phys. Chem. 70, 3798-3805.
45. Morse D., and, Choi A. M., (2002) Heme oxygenase-1: the "emerging molecule" has arrived. Am. J. Respir. Cell Mol. Biol. 27, 8-16.
46. Otterbein L. E., Hedblom A., Harris C., Csizmadia E., Gallo D., and, Wegiel B., (2011) Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein. Proc. Natl Acad. Sci. USA 108, 14491-14496.
47. Pasternack R. F., Gibbs E. J., Hoeflin E., Kosar W. P., Kubera G., Skowronek C. A., Wong N. M., and, Muller-Eberhard U., (1983) Hemin binding to serum proteins and the catalysis of interprotein transfer. Biochemistry 22, 1753-1758.
48. Qureshi A. I., Tuhrim S., Broderick J. P., Batjer H. H., Hondo H., and, Hanley D. F., (2001) Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 344, 1450-1460.
49. Reiter C. D., Wang X., Tanus-Santos J. E., Hogg N., Cannon R. O. III, Schechter A. N., and, Gladwin M. T., (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8, 1383-1389.
50. Rish K. R., Swartzlander R., Sadikot T. N., Berridge M. V., and, Smith A., (2007) Evidence that heme and heme-hemopexin interact with cell growth-associated plasma membrane electron transport. Biochem. Biophys. Acta Bioenerg. 1767, 1107-1117.
51. Rogers J. T., Randall J. D., Cahill C. M., et al,. (2002) An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 277, 45518-45528.
52. Schipper H. M., (2004) Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress. Ann. N. Y. Acad. Sci. 1012, 84-93.
53. Schipper H. M., Gupta A., and, Szarek W. A., (2009a) Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD. Curr. Alzheimer Res. 6, 424-430.
54. Schipper H. M., Song W., Zukor H., Hascalovici J. R., and, Zeligman D., (2009b) Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J. Neurochem. 110, 469-485.
55. Schobel S., Neumann S., Seed B., and, Lichtenthaler S. F., (2006) Expression cloning screen for modifiers of amyloid precursor protein shedding. Int. J. Dev. Neurosci. 24, 141-148.
56. Schroder E., and, Eaton P., (2008) Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations. Curr. Opin. Pharmacol. 8, 153-159.
57. Siesjo B. K., Katsura K., and, Kristian T., (1996) Acidosis-related damage. Adv. Neurol. 71, 209-236.
58. Smith A., (2011). Mechanisms of Cytoprotection by Hemopexin, in Handbook of Porphyrin Science. Biochemistry of Tetrapyrroles (, Kadish K. M., Smith K. M., and, Guilard R., eds), pp. 217-356. World Scientific Publishing Co. Pte. Ltd., Singapore.
59. Smith A., and, Morgan W. T., (1979) Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein. Biochem. J. 182, 47-54.
60. Song W., Su H., Song S., Paudel H. K., and, Schipper H. M., (2006) Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J. Cell. Physiol. 206, 655-663.
61. Song W., Zukor H., Lin S. H., et al,. (2012) Schizophrenia-like features in transgenic mice overexpressing human HO-1 in the astrocytic compartment. J. Neurosci. 32, 10841-10853.
62. Sung L., Morales P., Shibata M., Shipulina N., and, Smith A., (2000). Defenses against extracellular heme-mediated oxidative damage: use of iron and copper chelators to investigate the role of redox active iron, copper and heme in the hemopexin heme transport system, in Iron Chelators: New Development Strategies (, Badman D. G., Bergeron R. J., and, Brittenham G. M., eds), pp. 67-86. Saratoga Publishing Group, Sarotoga, FL.
63. Takahashi M., Dore S., Ferris C. D., et al,. (2000) Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 28, 461-473.
64. Test S. T., and, Weiss S. J., (1984) Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils. J. Biol. Chem. 259, 399-405.
65. Timmins G. S., Davies M. J., Song D. X., and, Muller-Eberhard U., (1995) EPR studies on the effects of complexation of heme by hemopexin upon its reactions with organic peroxides. Free Radic. Res. 23, 559-569.
66. Tong X. K., Nicolakakis N., Kocharyan A., and, Hamel E., (2005) Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J. Neurosci. 25, 11165-11174.
67. Vanacore R., Eskew J., Morales P., Sung L., and, Smith A., (2000) Role for copper in transient oxidation and nuclear translocation of MTF-1, but not of NFkB, by the hemopexin heme transport system. Antioxid. Redox Signal. 2, 739-752.
68. Vermeulen Windsant I. C., de Wit N. C., Sertorio J. T., Beckers E. A., Tanus-Santos J. E., Jacobs M. J., and, Buurman W. A., (2012) Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study. Crit. Care 16, R95.
69. Vincent S. H., Grady R. W., Shaklai N., Snider J. M., and, Muller-Eberhard U., (1988) The influence of heme-binding proteins in heme-catalyzed oxidations. Arch. Biochem. Biophys. 265, 539-550.
70. Wallevik K., (1973) Reversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotation. J. Biol. Chem. 248, 2650-2655.
71. Weiss S. J., (1989) Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365-376.
72. Yoshinaga T., Sassa S., and, Kappas A., (1982) The occurrence of molecular interactions among NADPH-cytochrome c reductase, heme oxygenase, and biliverdin reductase in heme degradation. J. Biol. Chem. 257, 7786-7793.
73. Zheng W., Xin N., Chi Z. H., Zhao B. L., Zhang J., Li J. Y., and, Wang Z. Y., (2009) Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation. FASEB J. 23, 4207-4217.